StockGlow

Avenue Therapeutics, Inc. (ATXI)

Develops pain and rare disease medications, including IV pain relief and Pompe disease treatments.

$0.30+0.20%Healthcare
Compare ATXI with
StockGlow Score
10
Bearish
BearishBullish
1 year ago-34.8%

The outlook

ATXI is trading well below its 50- and 200-day moving averages, near the lower end of its 52-week range. Analyst coverage appears thin or unavailable. The overall sentiment reflected in the data leans bearish.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range18% of the way from its 52-week low to high
Market cap
$988,490
52-wk high
$0.97
52-wk low
$0.15
50-day avg
$0.30
200-day avg
$0.46
Trailing P/E
—

Similar stocks

ARDSAridis Pharmaceuticals, Inc.$0.00+0.00%KPRXKiora Pharmaceuticals, Inc.$2.57+1.18%ADTXAditxt, Inc.$0.00-6.25%PALIPalisade Bio, Inc.$2.02-0.49%ENSCEnsysce Biosciences, Inc.$0.25-4.05%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy